These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30262122)

  • 1. Cost-utility analysis of smoking cessation to prevent operative complications following elective abdominal colon surgery.
    Kulaylat AS; Hollenbeak CS; Soybel DI
    Am J Surg; 2018 Dec; 216(6):1082-1089. PubMed ID: 30262122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental net monetary benefit of using varenicline for smoking cessation: A systematic review and meta-analysis of economic evaluation studies.
    Chaisai C; Patikorn C; Thavorn K; Lee SWH; Chaiyakunapruk N; Veettil SK
    Addiction; 2024 Jul; 119(7):1188-1202. PubMed ID: 38520121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
    Keeney E; Welton NJ; Stevenson M; Dalili MN; López-López JA; Caldwell DM; Phillippo DM; Munafò MR; Thomas KH
    Value Health; 2021 Jun; 24(6):780-788. PubMed ID: 34119075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of real-world administration of tobacco pharmacotherapy in the United States Veterans Health Administration.
    Barnett PG; Ignacio RV; Kim HM; Geraci MC; Essenmacher CA; Hall SV; Sherman SE; Duffy SA
    Addiction; 2019 Aug; 114(8):1436-1445. PubMed ID: 30924195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
    Tosanguan J; Chaiyakunapruk N
    Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Enhanced vs Standard Varenicline Treatment for Tobacco Cessation.
    Mundt MP; Stein JH; Fiore MC; Baker TB
    JAMA Netw Open; 2024 Apr; 7(4):e248727. PubMed ID: 38683609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M; Raymond V; Paradis PE
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea.
    Bae JY; Kim CH; Lee EK
    Value Health; 2009; 12 Suppl 3():S70-3. PubMed ID: 20586986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
    Rejas-Gutiérrez J; Bruguera E; Cedillo S
    Eur Psychiatry; 2017 Sep; 45():41-49. PubMed ID: 28728094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial benefit of a smoking cessation program prior to elective colorectal surgery.
    Gaskill CE; Kling CE; Varghese TK; Veenstra DL; Thirlby RC; Flum DR; Alfonso-Cristancho R
    J Surg Res; 2017 Jul; 215():183-189. PubMed ID: 28688645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
    Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N
    Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.